{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dose+Group+2&page=2", "query": { "intervention": "Dose Group 2", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dose+Group+2&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-19T18:07:43.819Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05286762", "title": "Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "ADHD", "Attention Deficit Hyperactivity Disorder", "ADHD - Combined Type", "Attention Deficit Hyperactivity Disorder Combined", "Attention-deficit Hyperactivity", "Attention Deficit Hyper Activity" ], "interventions": [ { "name": "CTx-1301-Dexmethylphenidate 12.5 mg (titration only)", "type": "DRUG" }, { "name": "CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)", "type": "DRUG" }, { "name": "CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose)", "type": "DRUG" }, { "name": "CTx-1301-Dexmethylphenidate 37.5 mg (randomized fixed dose)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cingulate Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 103, "start_date": "2023-08-01", "completion_date": "2024-02-29", "has_results": true, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 24, "location_summary": "Jacksonville, Florida • Maitland, Florida • Orlando, Florida + 21 more", "locations": [ { "city": "Jacksonville", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Springfield", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05286762" }, { "nct_id": "NCT03374956", "title": "Individualized Obesity Pharmacotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Phentermine-Topiramate", "type": "DRUG" }, { "name": "Liraglutide", "type": "DRUG" }, { "name": "Naltrexone/bupropion", "type": "DRUG" }, { "name": "Phentermine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 193, "start_date": "2017-12-11", "completion_date": "2022-05-26", "has_results": true, "last_update_posted_date": "2023-07-18", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03374956" }, { "nct_id": "NCT06217822", "title": "First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Metastatic Castration-resistant Prostate Cancer", "Prostate Specific Membrane Antigen (PSMA) Expression" ], "interventions": [ { "name": "225Ac-PSMA-Trillium (BAY3563254)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 198, "start_date": "2024-03-07", "completion_date": "2032-05-28", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 4, "location_summary": "Duarte, California • Minneapolis, Minnesota • Omaha, Nebraska + 1 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06217822" }, { "nct_id": "NCT00600353", "title": "Multi-day Doses in Prevention of Nausea and Emesis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myeloma, Plasma-Cell", "Lymphoma, Malignant" ], "interventions": [ { "name": "Palonosetron", "type": "DRUG" }, { "name": "Aprepitant", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2007-10", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2017-03-09", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00600353" }, { "nct_id": "NCT01436305", "title": "Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplantation", "Renal Transplantation" ], "interventions": [ { "name": "Alemtuzumab", "type": "DRUG" }, { "name": "MMF", "type": "DRUG" }, { "name": "Basiliximab", "type": "BIOLOGICAL" }, { "name": "Short-term Tac", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" }, { "name": "Belatacept", "type": "BIOLOGICAL" }, { "name": "methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 19, "start_date": "2011-09", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2017-09-27", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 3, "location_summary": "Birmingham, Alabama • San Francisco, California • Atlanta, Georgia", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01436305" }, { "nct_id": "NCT04908722", "title": "A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19 Prevention" ], "interventions": [ { "name": "Ad26.COV2.S", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Janssen Vaccines & Prevention B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 1609, "start_date": "2021-06-18", "completion_date": "2023-07-10", "has_results": true, "last_update_posted_date": "2025-02-04", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 18, "location_summary": "Little Rock, Arkansas • Anaheim, California • Long Beach, California + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Redding", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04908722" }, { "nct_id": "NCT02741739", "title": "Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "REGN1033", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 28, "start_date": "2016-03", "completion_date": "2016-05", "has_results": false, "last_update_posted_date": "2016-10-14", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02741739" }, { "nct_id": "NCT01496131", "title": "Tecemotide (L-BLP25) in Prostate Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Radiation therapy", "type": "RADIATION" }, { "name": "Goserelin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Tecemotide (L-BLP25)", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 28, "start_date": "2011-10-24", "completion_date": "2016-11-25", "has_results": true, "last_update_posted_date": "2018-03-09", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 1, "location_summary": "Rockland, Massachusetts", "locations": [ { "city": "Rockland", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01496131" }, { "nct_id": "NCT00066027", "title": "Effects of Low-Dose Doxycycline on Oral Bone Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Periodontitis" ], "interventions": [ { "name": "20 mg doxycycline hyclate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "45 Years to 70 Years · Female only" }, "enrollment_count": 128, "start_date": "2002-06-01", "completion_date": "2005-10-01", "has_results": false, "last_update_posted_date": "2023-09-06", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 2, "location_summary": "Lincoln, Nebraska • Stony Brook, New York", "locations": [ { "city": "Lincoln", "state": "Nebraska" }, { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00066027" }, { "nct_id": "NCT02254486", "title": "Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Colon Cancer", "Colorectal Carcinoma", "Colon Cleansing" ], "interventions": [ { "name": "NER1006", "type": "DRUG" }, { "name": "Trisulfate solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Norgine", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 621, "start_date": "2014-09", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2018-05-15", "last_synced_at": "2026-09-19T18:07:43.819Z", "location_count": 12, "location_summary": "Anaheim, California • Annapolis, Maryland • Chevy Chase, Maryland + 9 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Annapolis", "state": "Maryland" }, { "city": "Chevy Chase", "state": "Maryland" }, { "city": "Chesterfield", "state": "Michigan" }, { "city": "Great Neck", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02254486" } ] }